Your session is about to expire
← Back to Search
VisionPure Dietary Supplement for Eye Health
Study Summary
This trial is testing a dietary supplement (VisionPure) containing fish oil, lutein, zeaxanthin, and vitamin D to see if it helps maintain eye and cognitive health, and protects against blue light exposure. 16 people will be recruited and given either the supplement or a placebo for 60 days, after which they will have their eyesight and cognitive function tested.
- Eye Health
- Vision
- Cognitive Functioning
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there open spots available for the trial currently?
"According to information found on clinicaltrials.gov, this research is currently enrolling interested individuals. It was initially published on August 1st 2022 and the most recent update occurred October 12th of the same year."
Would I meet the qualifications for this research project?
"Only applicants with intact visual acuity, between 18 and 40 years of age are eligible for this research trial. As of now, 16 participants have been recruited."
What is the scale of the research sample involved in this experiment?
"Affirmative. According to the clinicaltrials.gov portal, this medical trial, which was first advertised on August 1st 2022, is still open for recruitment. 16 individuals need to be drawn from 3 distinct healthcare facilities."
What is the aim of this trial?
"According to the Applied Science & Performance Institute, which is sponsoring this study, there are two primary metrics of success - namely Change in Ganglion Cell Complex Thickness measured between Day 0 and 60. Additionally, secondary outcomes include but are not limited to: Change in Cognitive Attention (the capacity for multitasking); Change in Visual Memory (recognition/recall capability) and; Change in Color Vision (determined by Ishihara Plates)."
Are octogenarians eligible to participate in the experiment?
"This medical trial welcomes patients aged 18 and below 40 to participate."
Share this study with friends
Copy Link
Messenger